Lbp Am Sa Sells 465 Shares of Axon Enterprise, Inc (NASDAQ:AXON)

LBP AM SA decreased its holdings in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 3.7% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 12,128 shares of the biotechnology company's stock after selling 465 shares during the quarter. LBP AM SA's holdings in Axon Enterprise were worth $6,379,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Kentucky Retirement Systems Insurance Trust Fund bought a new position in Axon Enterprise in the first quarter worth $1,110,000. CX Institutional bought a new position in shares of Axon Enterprise during the first quarter valued at $115,000. GAMMA Investing LLC increased its holdings in shares of Axon Enterprise by 11.8% during the first quarter. GAMMA Investing LLC now owns 1,454 shares of the biotechnology company's stock valued at $765,000 after acquiring an additional 154 shares in the last quarter. DAVENPORT & Co LLC increased its holdings in shares of Axon Enterprise by 5.1% during the first quarter. DAVENPORT & Co LLC now owns 940 shares of the biotechnology company's stock valued at $494,000 after acquiring an additional 46 shares in the last quarter. Finally, Blue Trust Inc. increased its holdings in shares of Axon Enterprise by 33.1% during the first quarter. Blue Trust Inc. now owns 169 shares of the biotechnology company's stock valued at $89,000 after acquiring an additional 42 shares in the last quarter. Institutional investors own 79.08% of the company's stock.

Insider Buying and Selling

In other Axon Enterprise news, CRO Cameron Brooks sold 3,000 shares of the business's stock in a transaction dated Friday, May 30th. The shares were sold at an average price of $740.76, for a total value of $2,222,280.00. Following the completion of the sale, the executive directly owned 19,447 shares of the company's stock, valued at $14,405,559.72. The trade was a 13.36% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CAO Jennifer H. Mak sold 75 shares of the business's stock in a transaction dated Friday, June 13th. The shares were sold at an average price of $771.81, for a total transaction of $57,885.75. Following the completion of the sale, the chief accounting officer directly owned 15,240 shares of the company's stock, valued at approximately $11,762,384.40. This trade represents a 0.49% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 44,642 shares of company stock worth $30,500,428 over the last 90 days. Corporate insiders own 4.40% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on AXON. Wolfe Research began coverage on Axon Enterprise in a report on Monday. They set an "outperform" rating for the company. Barclays upped their price target on shares of Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a research report on Friday, May 9th. Bank of America raised their price objective on Axon Enterprise from $750.00 to $895.00 and gave the stock a "buy" rating in a research note on Wednesday, June 4th. Needham & Company LLC lifted their target price on shares of Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a research note on Thursday, May 8th. Finally, The Goldman Sachs Group lifted their price target on shares of Axon Enterprise from $730.00 to $830.00 and gave the company a "buy" rating in a report on Wednesday, May 14th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and eleven have issued a buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $699.55.

Axon Enterprise Price Performance

Shares of Axon Enterprise stock traded down $3.87 during trading hours on Friday, reaching $729.12. The company's stock had a trading volume of 663,931 shares, compared to its average volume of 706,239. The firm has a 50 day moving average price of $750.64 and a 200-day moving average price of $640.27. Axon Enterprise, Inc has a one year low of $279.02 and a one year high of $830.21. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.83 and a quick ratio of 2.62. The stock has a market cap of $56.76 billion, a P/E ratio of 176.12, a P/E/G ratio of 92.76 and a beta of 1.29.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 EPS for the quarter, beating the consensus estimate of $1.34 by $0.07. The company had revenue of $603.63 million for the quarter, compared to the consensus estimate of $585.67 million. Axon Enterprise had a net margin of 14.86% and a return on equity of 5.81%. The firm's revenue was up 31.3% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.15 EPS. On average, analysts predict that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.